The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is offering advanced development support to Hologic (NSDQ:HOLX) for a molecular diagnostic test for coronavirus (COVID-19). Marlborough, Mass.-based Hologic’s test is the first coronavirus product selected for development through ASPR’s biomedical advanced R&D authority streamlined selection process (BARDA), […]
InVivo Therapeutics prices $7m offering
InVivo Therapeutics (NSDQ:NVIV) announced last week that it priced a public offering of common stock shares and warrants totaling approximately $7 million. The offering is set to include more than 2.5 million shares of common stock or pre-funded warrants to purchase common stock, along with standard warrants to purchase up to more than 2.5 million shares […]
Supira Medical closes $35m Series B for its pVAD tech
Supira Medical announced that it closed a $35 million Series B financing round and appointed Nitin Salunke as its new president & CEO. Cormorant Asset Management led the financing, which officially closed on Feb. 25. The Capital Partnership, 415 Capital, AMED Ventures and Shifamed Angels all participated as well. Campbell, Calif.-based Supira Medical said in […]
TransEnterix registers public offering
TransEnterix (NYSE:TRXC) announced that it commenced an underwritten offering of units of common stock, warrants and convertible preferred stock. The offering is expected to be comprised of a unit of common stock with warrants to purchase shares of common stock and a unit of convertible preferred stock with warrants to purchase shares of common stock. According […]
Evonetix raises $30m for desktop gene synthesis tech
Evonetix announced today that it closed a $30 million Series B funding round as it develops technology for enabling gene synthesis on a chip. The Cambridge, U.K.-based synthetic biology company said the funding round, led by new investor Foresite Capital, is slated to fund the company through to the introduction of its desktop DNA platform, according […]
Adaptiiv Medical Technologies raises $1.8m
Adaptiiv Medical Technologies filed an amendment to its SEC Form D to confirm the sale of nearly $1.8 million in an equity offering. The Halifax, Nova Scotia-based cancer treatment software developer sold about $1.79 million in the $3 million offering, leaving just over $1.2 million remaining to be sold. Adaptiiv made the first sale on […]
NuVasive prices $450m offering
NuVasive (NSDQ:NUVA) yesterday announced the pricing of a $450 million offering of convertible senior notes in a private placement. The offering consists of an aggregate principal amount of 0.375% convertible notes due in 2025. The San Diego-based spine technology company also granted initial purchasers a 13-day option to purchase up to an additional $50 million aggregate […]
Viseon closes $18m Series B
Viseon announced yesterday that it closed a Series B financing round worth $18 million to support a number of company initiatives. The Irvine, Calif.-based orthopedic spine technology company said it is earmarking the funding for ongoing product development, worldwide regulatory approvals, clinical evaluations, manufacturing scale-up and commercialization efforts. The $18 million round was co-led by […]
Aria completes $31m Series B for its pulmonary hypertension treatment device
Pulmonary arterial hypertension (PAH) treatment developer Aria CV announced today that it completed a $31 million Series B financing round. The proceeds from the round, led by private equity and venture investor Xeraya Capital, are earmarked for funding St. Paul, Minn.–based Aria CV’s first U.S. clinical study. Aria CV’s early feasibility investigational study is set […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Myomo closes $15m public offering
Myomo (NYSE:MYO) announced that it closed its previously announced underwritten public offering of common stock or common stock equivalents for gross proceeds of $15 million. The offering included more than 2.1 million shares of Cambridge, Mass.–based Myomo’s common stock or equivalents, along with an equal amount of investor warrants to purchase one share of common stock […]
